The MicroRNA-21 in Autoimmune DiseasesReport as inadecuate

The MicroRNA-21 in Autoimmune Diseases - Download this document for free, or read online. Document in PDF available to download.

Shenzhen Laboratory of Fully Human Antibody Engineering, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China


Author to whom correspondence should be addressed.

Academic Editor: Y-h. Taguchi

Abstract MicroRNA-21 miR-21 is an oncomiR and significantly upregulated in a wide range of cancers. It is strongly involved in apoptosis and oncogenesis, since most of its reported targets are tumor suppressors. Recently, miR-21 was found to be correlated with the pathogenesis of autoimmune diseases and may play an essential role in regulating autoimmune responses. In particular, miR-21 promotes Th17 cell differentiation, which mediates the development of multiple autoimmune diseases. In this article, we review the current research on the mechanisms that regulate miR-21 expression, the potential of miR-21 as a diagnostic biomarker for autoimmune disease and the mechanisms by which miR-21 promotes the development of autoimmune disease. We also discussed the therapeutic potential of targeting miR-21 in treating patients with autoimmune disease. View Full-Text

Keywords: miR-21; autoimmune disease; Th17; apoptosis miR-21; autoimmune disease; Th17; apoptosis

Author: Shaowen Wang, Xiaochun Wan and Qingguo Ruan *



Related documents